Trial Parameters
Condition Oncology
Sponsor Sherief Abd-Elsalam
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 60
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2019-05-01
Completion 2030-12-01
Interventions
Pantoprazole low dosePantoprazole high doseStandard hydration
Brief Summary
Pantoprazole in Cisplatin Nephrotoxicity
Eligibility Criteria
Inclusion Criteria: * Patients with head and neck cancer Exclusion Criteria: * GFR less than 59. * DM * Elevated liver enzymes more than 3 fold.
Related Trials
NCT06558487
The Internal Prospective Validation of the Cancer Admission Score (CAS) Prediction Model
View Trial →
NCT03118986
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
View Trial →
NCT05748210
A Symptom Management Application for Children at the Early Stage of Cancer Survivorship and Their Ca
View Trial →